1. Home
  2. LXRX vs KE Comparison

LXRX vs KE Comparison

Compare LXRX & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • KE
  • Stock Information
  • Founded
  • LXRX 1995
  • KE 1961
  • Country
  • LXRX United States
  • KE United States
  • Employees
  • LXRX N/A
  • KE N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • KE Electrical Products
  • Sector
  • LXRX Health Care
  • KE Technology
  • Exchange
  • LXRX Nasdaq
  • KE Nasdaq
  • Market Cap
  • LXRX 428.8M
  • KE 459.3M
  • IPO Year
  • LXRX 2000
  • KE N/A
  • Fundamental
  • Price
  • LXRX $1.09
  • KE $31.32
  • Analyst Decision
  • LXRX Buy
  • KE Strong Buy
  • Analyst Count
  • LXRX 5
  • KE 1
  • Target Price
  • LXRX $3.23
  • KE $28.00
  • AVG Volume (30 Days)
  • LXRX 1.6M
  • KE 258.2K
  • Earning Date
  • LXRX 11-11-2025
  • KE 11-03-2025
  • Dividend Yield
  • LXRX N/A
  • KE N/A
  • EPS Growth
  • LXRX N/A
  • KE N/A
  • EPS
  • LXRX N/A
  • KE 0.68
  • Revenue
  • LXRX $58,432,000.00
  • KE $1,486,727,000.00
  • Revenue This Year
  • LXRX N/A
  • KE N/A
  • Revenue Next Year
  • LXRX N/A
  • KE $4.02
  • P/E Ratio
  • LXRX N/A
  • KE $45.93
  • Revenue Growth
  • LXRX 1504.83
  • KE N/A
  • 52 Week Low
  • LXRX $0.28
  • KE $12.41
  • 52 Week High
  • LXRX $2.18
  • KE $31.70
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 47.78
  • KE 81.76
  • Support Level
  • LXRX $1.03
  • KE $29.40
  • Resistance Level
  • LXRX $1.19
  • KE $30.85
  • Average True Range (ATR)
  • LXRX 0.06
  • KE 0.79
  • MACD
  • LXRX -0.00
  • KE -0.12
  • Stochastic Oscillator
  • LXRX 35.29
  • KE 89.14

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

Share on Social Networks: